BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

CRISPR Gene Editing Opens New Treatment Avenues for Alzheimer's

Two new CRISPR-based strategies offer hope for next-generation Alzheimer's treatments. One seeks to dampen the impact of the most common Alzheimer's ris...

July 17, 2023 | News

OneStudyTeam Expands Global Research Reach to 4,000 Sites Across EMEA, LATAM, and Asia-Pacific

OneStudyTeam, the maker of the patient enrollment management platform StudyTeam, today announced that StudyTeam is now being used by more than 4,000 clinic...

July 17, 2023 | News

Raya Therapeutic announces early-stage R&D collaboration with argenx

"We are delighted to be entering this early-stage R&D collaboration with argenx. argenx is one of the industry's most exciting companies, and their bel...

July 13, 2023 | News

TCI Unveils VeCollal®: Biomimetic Collagen Mirroring Human Collagen, Validated by Belgian Clinical Study

In recent years, the growing awareness among consumers regarding environmental protection and health has driven the demand for vegan collagen. This growing...

July 12, 2023 | News

Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All

With the inauguration of a new state-of-the-art cell therapy lab in early 2022, BeiGene is looking to broaden collaboration and expand ...

July 12, 2023 | News

Broncus Completes First Registered Clinical Trials of Targeted Lung Denervation System

The multi-center clinical randomized controlled trial on the ''treatment of Chronic Obstructive Pulmonary Disease (''COPD'') by targeted lung denervation a...

July 11, 2023 | News

RemeGen and Innovent Collaborate on Clinical Trials for Advanced Solid Tumors

RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, announce...

July 10, 2023 | News

280 Bio receives IND approval from the FDA for YL-17231

80Bio, Inc. a clinical stage biotechnology company focused on the development of precision oncology medicines, today announced that the U.S. Food and Drug ...

July 10, 2023 | News

GeneQuantum Healthcare and Aimed Bio collaborate to develop 5 innovative ADC drugs

Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...

July 07, 2023 | News

PrecisionLife licenses Oxford data for personalized endometriosis treatments

PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the Univ...

July 07, 2023 | News

GenScript Doubles cGMP sgRNA and Non-Viral DNA Payload Manufacturing Capacity

GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its cGMP manufacturing capacity...

July 07, 2023 | News

China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy

RareStone Group, a rare disease-focused company aiming to establish the first rare disease ecosystem in China, announced that on June 30, the Chi...

July 05, 2023 | News

FDA Approves Cu-64 SAR-bisPSMA Phase III Trial for Prostate Cancer

FDA agreement for a pivotal Phase III trial for 64Cu SAR-bisPSMA diagnostic in prostate cancer Phase III trial design based on&n...

July 05, 2023 | News

Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China

The pivotal clinical trial approved in China will evaluate the efficacy and safety of Glecirasib as a single agent for the second line treatment ...

July 05, 2023 | News

Stay Connected